These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 34083670)
21. Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the U.S. population. Younossi ZM; Stepanova M Hepatology; 2011 Oct; 54(4):1167-78. PubMed ID: 21725988 [TBL] [Abstract][Full Text] [Related]
22. Trends in Chronic Liver Disease-Related Hospitalizations: A Population-Based Study. Asrani SK; Hall L; Hagan M; Sharma S; Yeramaneni S; Trotter J; Talwalkar J; Kanwal F Am J Gastroenterol; 2019 Jan; 114(1):98-106. PubMed ID: 30333543 [TBL] [Abstract][Full Text] [Related]
23. Use of Telemedicine for Chronic Liver Disease at a Single Care Center During the COVID-19 Pandemic: Prospective Observational Study. Guarino M; Cossiga V; Fiorentino A; Pontillo G; Morisco F J Med Internet Res; 2020 Sep; 22(9):e20874. PubMed ID: 32896833 [TBL] [Abstract][Full Text] [Related]
25. Implications of liver injury in risk-stratification and management of patients with COVID-19. Shao J; Liang Y; Li Y; Ding R; Zhu M; You W; Wang Z; Huang B; Wu M; Zhang T; Li K; Wu W; Wu L; Wang Q; Xia X; Wang S; Lu L Hepatol Int; 2021 Feb; 15(1):202-212. PubMed ID: 33548030 [TBL] [Abstract][Full Text] [Related]
26. Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases. Kusumi E; Kami M; Kanda Y; Murashige N; Seki K; Fujiwara M; Koyama R; Komatsu T; Hori A; Tanaka Y; Yuji K; Matsumura T; Masuoka K; Wake A; Miyakoshi S; Taniguchi S Biol Blood Marrow Transplant; 2006 Dec; 12(12):1302-9. PubMed ID: 17162212 [TBL] [Abstract][Full Text] [Related]
27. Chronic liver disease in central Harlem: the role of alcohol and viral hepatitis. Frieden TR; Ozick L; McCord C; Nainan OV; Workman S; Comer G; Lee TP; Byun KS; Patel D; Henning KJ Hepatology; 1999 Mar; 29(3):883-8. PubMed ID: 10051493 [TBL] [Abstract][Full Text] [Related]
28. Predictors for the severe coronavirus disease 2019 (COVID-19) infection in patients with underlying liver disease: a retrospective analytical study in Iran. Bahardoust M; Heiat M; Khodabandeh M; Karbasi A; Bagheri-Hosseinabadi Z; Ataee MH; Seidalian N; Babazadeh A; Agah S; Abyazi MA Sci Rep; 2021 Feb; 11(1):3066. PubMed ID: 33542426 [TBL] [Abstract][Full Text] [Related]
29. Comorbidity and clinical factors associated with COVID-19 critical illness and mortality at a large public hospital in New York City in the early phase of the pandemic (March-April 2020). Filardo TD; Khan MR; Krawczyk N; Galitzer H; Karmen-Tuohy S; Coffee M; Schaye VE; Eckhardt BJ; Cohen GM PLoS One; 2020; 15(11):e0242760. PubMed ID: 33227019 [TBL] [Abstract][Full Text] [Related]
30. The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital. Yang Y; Zhang XZ; Ng HS; Fong JC; Lee LH Thromb Res; 2015 Sep; 136(3):548-51. PubMed ID: 26164397 [TBL] [Abstract][Full Text] [Related]
31. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients. Dorjee K; Kim H; Bonomo E; Dolma R PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825 [TBL] [Abstract][Full Text] [Related]
32. Short-term clinical outcomes of patients admitted with chronic liver disease to selected teaching hospitals in Ethiopia. Terefe Tesfaye B; Gudina EK; Bosho DD; Mega TA PLoS One; 2019; 14(8):e0221806. PubMed ID: 31469861 [TBL] [Abstract][Full Text] [Related]
33. Current and Future Burden of Chronic Nonmalignant Liver Disease. Udompap P; Kim D; Kim WR Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2031-41. PubMed ID: 26291665 [TBL] [Abstract][Full Text] [Related]
34. Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease. Yue X; Black CL; O'Halloran A; Lu PJ; Williams WW; Nelson NP Vaccine; 2018 Feb; 36(9):1183-1189. PubMed ID: 29395521 [TBL] [Abstract][Full Text] [Related]
35. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors. Yin T; Li Y; Ying Y; Luo Z BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678 [TBL] [Abstract][Full Text] [Related]
36. Hepatorenal syndrome in hospitalized patients with chronic liver disease: results from the Nationwide Inpatient Sample 2002-2012. Pant C; Jani BS; Desai M; Deshpande A; Pandya P; Taylor R; Gilroy R; Olyaee M J Investig Med; 2016 Jan; 64(1):33-8. PubMed ID: 26755811 [TBL] [Abstract][Full Text] [Related]
37. Disparity in liver cancer incidence and chronic liver disease mortality by nativity in Hispanics: The Multiethnic Cohort. Setiawan VW; Wei PC; Hernandez BY; Lu SC; Monroe KR; Le Marchand L; Yuan JM Cancer; 2016 May; 122(9):1444-52. PubMed ID: 26916271 [TBL] [Abstract][Full Text] [Related]
38. The mortality burden of chronic liver disease may be substantially underestimated in the United States. Durante AJ; St Louis T; Meek JI; Navarro VJ; Sofair AN Conn Med; 2008 Aug; 72(7):389-92. PubMed ID: 18763665 [TBL] [Abstract][Full Text] [Related]
39. Acute gastrointestinal injury in critically ill patients with COVID-19 in Wuhan, China. Sun JK; Liu Y; Zou L; Zhang WH; Li JJ; Wang Y; Kan XH; Chen JD; Shi QK; Yuan ST World J Gastroenterol; 2020 Oct; 26(39):6087-6097. PubMed ID: 33132657 [TBL] [Abstract][Full Text] [Related]
40. The safety and pharmacokinetics of metformin in patients with chronic liver disease. Smith FC; Stocker SL; Danta M; Carland JE; Kumar SS; Liu Z; Greenfield JR; Braithwaite HE; Cheng TS; Graham GG; Williams KM; Day RO Aliment Pharmacol Ther; 2020 Mar; 51(5):565-575. PubMed ID: 31960986 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]